2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

2018 ESC/EACTS Guidelines on myocardial revascularization

M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

2018 ESC/EACTS Guidelines on myocardial revascularization

FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

[HTML][HTML] Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy

EE Babes, C Bustea, T Behl, MM Abdel-Daim… - Biomedicine & …, 2022 - Elsevier
Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …

Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery …

S Bangalore, Y Guo, Z Samadashvili, S Blecker… - Circulation, 2016 - Am Heart Assoc
Background—Guidelines recommend coronary artery bypass graft surgery (CABG) over
percutaneous coronary intervention (PCI) for multivessel disease and severe left ventricular …

Paclitaxel-eluting versus everolimus-eluting coronary stents in diabetes

U Kaul, S Bangalore, A Seth, P Arambam… - … England Journal of …, 2015 - Mass Medical Soc
Background The choice of drug-eluting stent in the treatment of patients with diabetes
mellitus and coronary artery disease who are undergoing percutaneous coronary …

Bypass surgery or stenting for left main coronary artery disease in patients with diabetes

M Milojevic, PW Serruys, JF Sabik, DE Kandzari… - Journal of the American …, 2019 - jacc.org
Abstract Background: The randomized EXCEL (Evaluation of XIENCE versus Coronary
Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a …

Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes

T Sugiyama, E Yamamoto, K Bryniarski… - Journal of the …, 2018 - Am Heart Assoc
Background Diabetes mellitus (DM) is a major risk factor for cardiovascular events. We
aimed to investigate the coronary plaque phenotype of diabetic patients who presented with …

Translational tissue-engineered vascular grafts: From bench to bedside

L West-Livingston, JW Lim, SJ Lee - Biomaterials, 2023 - Elsevier
Cardiovascular disease is a primary cause of mortality worldwide, and patients often require
bypass surgery that utilizes autologous vessels as conduits. However, the limited availability …

Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non–ST Elevation Myocardial Infarction …

A Pandey, DK McGuire, JA de Lemos… - … Quality and Outcomes, 2016 - Am Heart Assoc
Background—Current guidelines recommend surgical revascularization (coronary artery
bypass graft [CABG]) over percutaneous coronary intervention (PCI) in patients with …